We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$1.59B
AUM Growth
+$283M
Cap. Flow
+$228M
Cap. Flow %
14.35%
Top 10 Hldgs %
6.1%
Holding
1,532
New
540
Increased
294
Reduced
266
Closed
432

Top Buys

Rank Stock Value
1
JCI icon
Johnson Controls International
JCI
+$11.9M
2
BMO icon
Bank of Montreal
BMO
+$10.5M
3
HPQ icon
HP
HPQ
+$9.75M
4
AER icon
AerCap
AER
+$9.53M
5
ITW icon
Illinois Tool Works
ITW
+$8.27M

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$8.73M
2
SYF icon
Synchrony
SYF
+$8.42M
3
CAH icon
Cardinal Health
CAH
+$7.63M
4
BRO icon
Brown & Brown
BRO
+$7.55M
5
UL icon
Unilever
UL
+$7.37M

Sector Composition

Rank Sector Weight
1 Technology 18.67%
2 Financials 17.36%
3 Industrials 17.08%
4 Consumer Discretionary 12.43%
5 Healthcare 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARCB icon
1126
ArcBest
ARCB
$3.14B
-8,641
Closed -$610K
ARDX icon
1127
Ardelyx
ARDX
$1.03B
-22,120
Closed -$109K
ARES icon
1128
Ares Management
ARES
$32.1B
-6,717
Closed -$985K
ARLO icon
1129
Arlo Technologies
ARLO
$1.5B
-12,698
Closed -$125K
ARW icon
1130
Arrow Electronics
ARW
$10.7B
-10,606
Closed -$1.1M
ASH icon
1131
Ashland
ASH
$3.42B
-69,270
Closed -$4.11M
ASND icon
1132
Ascendis Pharma A/S
ASND
$16.8B
-13,036
Closed -$2.03M
ASPN icon
1133
Aspen Aerogels
ASPN
$510M
-109,728
Closed -$701K
ATEN icon
1134
A10 Networks
ATEN
$2B
-19,214
Closed -$314K
ATO icon
1135
Atmos Energy
ATO
$28.7B
-19,624
Closed -$3.03M
AUB icon
1136
Atlantic Union Bankshares
AUB
$6.06B
-69,341
Closed -$2.16M
AVNS
1137
DELISTED
Avanos Medical
AVNS
-32,536
Closed -$466K
AVTR icon
1138
Avantor
AVTR
$9.42B
-23,049
Closed -$374K
AWR icon
1139
American States Water
AWR
$3.49B
-18,687
Closed -$1.47M
AXP icon
1140
American Express
AXP
$232B
-11,566
Closed -$3.11M
AXS icon
1141
AXIS Capital
AXS
$7.26B
-4,489
Closed -$450K
AZTA icon
1142
Azenta
AZTA
$1.47B
-28,060
Closed -$972K
BABA icon
1143
Alibaba
BABA
$300B
-6,986
Closed -$924K
BAC icon
1144
Bank of America
BAC
$453B
-29,703
Closed -$1.24M
BALL icon
1145
Ball Corp
BALL
$16.4B
-32,789
Closed -$1.71M
BAP icon
1146
Credicorp
BAP
$29.6B
-7,453
Closed -$1.39M
BFS
1147
Saul Centers
BFS
$850M
-15,221
Closed -$549K
BILI icon
1148
Bilibili
BILI
$7.37B
-18,214
Closed -$348K
BIO icon
1149
Bio-Rad Laboratories Class A
BIO
$9.68B
-6,443
Closed -$1.57M
BJ icon
1150
BJs Wholesale Club
BJ
$11.8B
-15,407
Closed -$1.76M

Similar funds

Campbell & Co Investment Adviser's Q2 2025 Portfolio in Review

As of Q2 2025, Campbell & Co Investment Adviser held 1,532 positions worth $1.59B, up 22% from $1.3B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Campbell & Co Investment Adviser deployed $228M of net new capital in Q2 2025, opening 540 new positions and adding to 294 existing holdings. Its largest new stake was Johnson Controls International: 128,951 shares worth $13.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 9.9% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cardinal Health, an estimated $7.63M trimmed.

  • Campbell & Co Investment Adviser's largest Q2 2025 buy was Johnson Controls International: 128,951 shares worth $13.6M.
  • Campbell & Co Investment Adviser added most to Dover in Q2 2025, an estimated $7.63M increase.
  • Campbell & Co Investment Adviser's biggest Q2 2025 reduction was Cardinal Health, cutting an estimated $7.63M.
  • Campbell & Co Investment Adviser fully exited Labcorp in Q2 2025, selling an estimated $8.73M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6.1% of its $1.59B portfolio in Q2 2025.
  • Campbell & Co Investment Adviser opened 540 new positions and closed 432 in Q2 2025.
  • Campbell & Co Investment Adviser's portfolio value rose 22% quarter-over-quarter to $1.59B.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2025, filed 7 Aug 2025.